Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rainer J. Klement. (2019) The influence of ketogenic therapy on the 5 R’s of radiobiology. International Journal of Radiation Biology 95:4, pages 394-407.
Read now
Read now
Michael Baumann, Mechthild Krause, Howard Thames, Klaus Trott & Daniel Zips. (2009) Cancer stem cells and radiotherapy. International Journal of Radiation Biology 85:5, pages 391-402.
Read now
Read now
K.‐R. Trott. (2003) Perspectives of experimental research on repopulation during radiotherapy. International Journal of Radiation Biology 79:7, pages 577-580.
Read now
Read now
Articles from other publishers (49)
Alexander H Staudacher, Vasilios Liapis & Michael P Brown. (2018) Therapeutic targeting of tumor hypoxia and necrosis with antibody α-radioconjugates. Antibody Therapeutics 1:2, pages 55-63.
Crossref
Crossref
Lydia Koi, Steffen Löck, Annett Linge, Cedric Thurow, Sandra Hering, Michael Baumann, Mechthild Krause & Kristin Gurtner. (2017) EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft models. Radiotherapy and Oncology 124:3, pages 496-503.
Crossref
Crossref
Mechthild Krause, Anna Dubrovska, Annett Linge & Michael Baumann. (2017) Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments. Advanced Drug Delivery Reviews 109, pages 63-73.
Crossref
Crossref
Arnulf Mayer, Sebastian Zahnreich, Jürgen Brieger, Peter Vaupel & Heinz Schmidberger. (2016) Downregulation of EGFR in hypoxic, diffusion-limited areas of squamous cell carcinomas of the head and neck. British Journal of Cancer 115:11, pages 1351-1358.
Crossref
Crossref
Shozo Okamoto, Tohru Shiga, Koichi Yasuda, Shiro Watanabe, Kenji Hirata, Ken-ichi Nishijima, Keiichi Magota, Katsuhiko Kasai, Rikiya Onimaru, Kazuhiko Tuchiya, Yuji Kuge, Hiroki Shirato & Nagara Tamaki. (2016) The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging 43:12, pages 2147-2154.
Crossref
Crossref
Michael Baumann, Mechthild Krause, Jens Overgaard, Jürgen Debus, Søren M. Bentzen, Juliane Daartz, Christian Richter, Daniel Zips & Thomas Bortfeld. (2016) Radiation oncology in the era of precision medicine. Nature Reviews Cancer 16:4, pages 234-249.
Crossref
Crossref
Geoff S Higgins, Mechthild Krause, W Gillies McKenna & Michael Baumann. 2016. Molecular Radio-Oncology. Molecular Radio-Oncology
107
122
.
Shyhmin Huang, H. Peter Rodemann & Paul M. Harari. 2016. Molecular Radio-Oncology. Molecular Radio-Oncology
45
87
.
Chowdhury Nusrat Fatema, Songji Zhao, Yan Zhao, Wenwen Yu, Ken-ichi Nishijima, Koichi Yasuda, Yoshimasa Kitagawa, Nagara Tamaki & Yuji Kuge. (2014) Dual tracer evaluation of dynamic changes in intratumoral hypoxic and proliferative states after radiotherapy of human head and neck cancer xenografts using radiolabeled FMISO and FLT. BMC Cancer 14:1.
Crossref
Crossref
Scott N. Penfold, Michael P. Brown, Alexander H. Staudacher & Eva Bezak. (2014) Monte Carlo simulations of dose distributions with necrotic tumor targeted radioimmunotherapy. Applied Radiation and Isotopes 90, pages 40-45.
Crossref
Crossref
JIA YANG, JIN-BO YUE, JING LIU & JIN-MING YU. (2014) Repopulation of tumor cells during fractionated radiotherapy and detection methods (Review). Oncology Letters 7:6, pages 1755-1760.
Crossref
Crossref
Jin-Bo Yue, Jia Yang, Jing Liu, Jason Lee, Alvin R. Cabrera, Xin-Dong Sun, Guang-Hui Bai, Yu-Hui Li & Jin-Ming Yu. (2014) Histopathologic validation of 3′-deoxy-3′-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice18F-FLT PET repopulation -->. Radiotherapy and Oncology 111:3, pages 475-481.
Crossref
Crossref
J Jeong, K I Shoghi & J O Deasy. (2013) Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response. Physics in Medicine and Biology 58:14, pages 4897-4919.
Crossref
Crossref
A Paliga, R Onerheim, A Gologan, G Chong, A Spatz, T Niazi, A Garant, D Macheto, T Alcindor & T Vuong. (2012) EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?. British Journal of Cancer 107:11, pages 1864-1868.
Crossref
Crossref
Yuta Shibamoto, Chisa Hashizume, Fumiya Baba, Shiho Ayakawa, Yoshihiko Manabe, Aiko Nagai, Akifumi Miyakawa, Taro Murai, Hiromitsu Iwata,Yoshimasa Mori, Mikio Mimura & Satoshi Ishikura. (2011) Stereotactic body radiotherapy using a radiobiology‐based regimen for stage I nonsmall cell lung cancer. Cancer 118:8, pages 2078-2084.
Crossref
Crossref
Constantin-Alin Maftei, Christine Bayer, Kuangyu Shi, Sabrina T. Astner & Peter Vaupel. (2011) Changes in the fraction of total hypoxia and hypoxia subtypes in human squamous cell carcinomas upon fractionated irradiation: Evaluation using pattern recognition in microcirculatory supply units. Radiotherapy and Oncology 101:1, pages 209-216.
Crossref
Crossref
Emily F. Dunn, Shyhmin Huang & Paul M. Harari. 2011. Molecular Determinants of Radiation Response. Molecular Determinants of Radiation Response
201
226
.
Alina Santiago, Wolfgang Eicheler, Jan Bussink, Paul Rijken, Ala Yaromina, Bettina Beuthien-Baumann, Albert J. van der Kogel, Michael Baumann & Mechthild Krause. (2010) Effect of cetuximab and fractionated irradiation on tumour micro-environment. Radiotherapy and Oncology 97:2, pages 322-329.
Crossref
Crossref
Wendy Harriss, E. Bezak, E. Yeoh & M. Hermans. (2010) Measurement of reoxygenation during fractionated radiotherapy in head and neck squamous cell carcinoma xenografts. Australasian Physical & Engineering Sciences in Medicine 33:3, pages 251-263.
Crossref
Crossref
Emmanouil Fokas, Jörg Hänze, Florentine Kamlah, Bastian G. Eul, Nico Lang, Boris Keil, Johannes T. Heverhagen, Rita Engenhart-Cabillic, Hanxiang An & Frank Rose. (2010) Irradiation-Dependent Effects on Tumor Perfusion and Endogenous and Exogenous Hypoxia Markers in an A549 Xenograft Model. International Journal of Radiation Oncology*Biology*Physics 77:5, pages 1500-1508.
Crossref
Crossref
Ala Yaromina, Howard Thames, Xuanjing Zhou, Sandra Hering, Wolfgang Eicheler, Annegret Dörfler, Thomas Leichtner, Daniel Zips & Michael Baumann. (2010) Radiobiological hypoxia, histological parameters of tumour microenvironment and local tumour control after fractionated irradiation. Radiotherapy and Oncology 96:1, pages 116-122.
Crossref
Crossref
N. O'Rourke & F. Macbeth. (2010) Is Concurrent Chemoradiation the Standard of Care for Locally Advanced Non-small Cell Lung Cancer? A Review of Guidelines and Evidence. Clinical Oncology 22:5, pages 347-355.
Crossref
Crossref
Ulrike Koch, Mechthild Krause & Michael Baumann. (2010) Cancer stem cells at the crossroads of current cancer therapy failures—Radiation oncology perspective. Seminars in Cancer Biology 20:2, pages 116-124.
Crossref
Crossref
Daniel Zips, Mechthild Krause, Ala Yaromina, Annegret Dörfler, Wolfgang Eicheler, Christina Schütze, Kristin Gurtner & Michael Baumann. (2008) Epidermal growth factor receptor inhibitors for radiotherapy: biological rationale and preclinical results. Journal of Pharmacy and Pharmacology 60:8, pages 1019-1028.
Crossref
Crossref
Nils Cordes, Stephanie Hehlgans & Iris Eke. 2009. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies
93
115
.
Michael Baumann & Mechthild Krause. 2009. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies
323
334
.
Daniel Zips. 2009. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies
291
298
.
Jacques Bernier. (2008) Incorporation of Molecularly Targeted Agents in the Primary Treatment of Squamous Cell Carcinomas of the Head and Neck. Hematology/Oncology Clinics of North America 22:6, pages 1193-1208.
Crossref
Crossref
Mechthild Krause & Michael Baumann. (2008) Clinical biomarkers of kinase activity: examples from EGFR inhibition trials. Cancer and Metastasis Reviews 27:3, pages 387-402.
Crossref
Crossref
Rob Glynne-Jones & Peter Hoskin. (2007) Neoadjuvant Cisplatin Chemotherapy Before Chemoradiation: A Flawed Paradigm?. Journal of Clinical Oncology 25:33, pages 5281-5286.
Crossref
Crossref
Mahmoud Toulany, Michael Baumann & H. Peter Rodemann. (2007) Stimulated PI3K-AKT Signaling Mediated through Ligand or Radiation-Induced EGFR Depends Indirectly, but not Directly, on Constitutive K-Ras Activity. Molecular Cancer Research 5:8, pages 863-872.
Crossref
Crossref
G.D. Wilson. (2007) Cell Kinetics. Clinical Oncology 19:6, pages 370-384.
Crossref
Crossref
Michael Baumann, Mechthild Krause, Ekkehard Dikomey, Klaus Dittmann, Wolfgang Dörr, Ulla Kasten-Pisula & H. Peter Rodemann. (2007) EGFR-targeted anti-cancer drugs in radiotherapy: Preclinical evaluation of mechanisms. Radiotherapy and Oncology 83:3, pages 238-248.
Crossref
Crossref
C. Hennequin. (2007) Les thérapeutiques ciblées en association avec la radiothérapie dans le cancer bronchique. Cancer/Radiothérapie 11:1-2, pages 77-83.
Crossref
Crossref
Jesper Grau Eriksen & Michael R. Horsman. (2006) Tumour hypoxia – A characteristic feature with a complex molecular background. Radiotherapy and Oncology 81:2, pages 119-121.
Crossref
Crossref
Mechthild Krause, Daniel Zips, Howard D. Thames, Johann Kummermehr & Michael Baumann. (2006) Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy. Radiotherapy and Oncology 80:2, pages 112-122.
Crossref
Crossref
Mahmoud Toulany, Ulla Kasten-Pisula, Ingo Brammer, Shaomeng Wang, Jianyong Chen, Klaus Dittmann, Michael Baumann, Ekkehard Dikomey & H. Peter Rodemann. (2006)
Blockage of Epidermal Growth Factor Receptor-Phosphatidylinositol 3-Kinase-AKT Signaling Increases Radiosensitivity of K-
RAS
Mutated Human Tumor Cells
In vitro
by Affecting DNA Repair
. Clinical Cancer Research 12:13, pages 4119-4126.
Crossref
Crossref
Michael I. Koukourakis, Søren M. Bentzen, Alexandra Giatromanolaki, George D. Wilson, Frances M. Daley, Michele I. Saunders, Stanley Dische, Efthimios Sivridis & Adrian L. Harris. (2006) Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized Trial. Journal of Clinical Oncology 24:5, pages 727-735.
Crossref
Crossref
Henning Willers & Kathryn D. Held. (2006) Introduction to Clinical Radiation Biology. Hematology/Oncology Clinics of North America 20:1, pages 1-24.
Crossref
Crossref
Sophie Pinel, Pascal Chastagner, Jean-Louis Merlin, Christian Marchal, Alphonse Taghian & Muriel Barberi-Heyob. (2005) Topotecan Can Compensate for Protracted Radiation Treatment Time Effects in High Grade Glioma Xenografts*. Journal of Neuro-Oncology 76:1, pages 31-38.
Crossref
Crossref
Dirk Vordermark, Peter Kraft, Astrid Katzer, Tobias Bölling, Jochen Willner & Michael Flentje. (2005) Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1α (HIF-1α). Cancer Letters 230:1, pages 122-133.
Crossref
Crossref
Wolfgang Eicheler, Mechthild Krause, Franziska Hessel, Daniel Zips & Michael Baumann. (2005) Kinetics of EGFR expression during fractionated irradiation varies between different human squamous cell carcinoma lines in nude mice. Radiotherapy and Oncology 76:2, pages 151-156.
Crossref
Crossref
Ala Yaromina, Tobias Hölscher, Wolfgang Eicheler, Andrea Rosner, Mechthild Krause, Franziska Hessel, Cordula Petersen, Howard D. Thames, Michael Baumann & Daniel Zips. (2005) Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?. Radiotherapy and Oncology 76:2, pages 206-212.
Crossref
Crossref
John J. Kim & Ian F. Tannock. (2005) Repopulation of cancer cells during therapy: an important cause of treatment failure. Nature Reviews Cancer 5:7, pages 516-525.
Crossref
Crossref
Cordula Petersen, Daniel Zips, Mechthild Krause, Wolfram Völkel, Howard D. Thames & Michael Baumann. (2005) Recovery from sublethal damage during fractionated irradiation of human FaDu SCC. Radiotherapy and Oncology 74:3, pages 331-336.
Crossref
Crossref
Jordi Giralt, Manuel de las Heras, Laura Cerezo, Aranzazu Eraso, Edurado Hermosilla, Dolores Velez, Juan Lujan, Eloi Espin, Jose Rossello, Joaquin Majó, Sergi Benavente, Manel Armengol & I. de Torres. (2005) The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis. Radiotherapy and Oncology 74:2, pages 101-108.
Crossref
Crossref
Tomoaki YAHIRO, Shigeki MASUI, Nobuo KUBOTA, Koji YAMADA, Ataru KOBAYASHI & Kenichi KISHII. (2005) Effects of Hypoxic Cell Radiosensitizer Doranidazole (PR-350) on the Radioresponse of Murine and Human Tumor Cells in vitro and in vivo. Journal of Radiation Research 46:3, pages 363-372.
Crossref
Crossref
Michael Baumann & Mechthild Krause. (2004) Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results. Radiotherapy and Oncology 72:3, pages 257-266.
Crossref
Crossref
Bruce M. Fenton, Scott F. Paoni & Ivan Ding. (2004) Pathophysiological Effects of Vascular Endothelial Growth Factor Receptor-2-Blocking Antibody plus Fractionated Radiotherapy on Murine Mammary Tumors. Cancer Research 64:16, pages 5712-5719.
Crossref
Crossref